Unknown

Dataset Information

0

Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic.


ABSTRACT:

Background

Before pandemic (H1N1) 2009, less than 10% of serum samples collected from all age groups in the Lower Mainland of British Columbia, Canada, showed seroprotection against the pandemic (H1N1) 2009 virus, except those from very elderly people. We reassessed this profile of seroprotection by age in the same region six months after the fall 2009 pandemic and vaccination campaign.

Methods

We evaluated 100 anonymized serum samples per 10-year age group based on convenience sampling. We measured levels of antibody against the pandemic virus by hemagglutination inhibition and microneutralization assays. We assessed geometric mean titres and the proportion of people with seroprotective antibody levels (hemagglutination inhibition titre ? 40). We performed sensitivity analyses to evaluate titre thresholds of 80, 20 and 10.

Results

Serum samples from 1127 people aged 9 months to 101 years were obtained. The overall age-standardized proportion of people with seroprotective antibody levels was 46%. A U-shaped age distribution was identified regardless of assay or titre threshold applied. Among those less than 20 years old and those 80 years and older, the prevalence of seroprotection was comparably high at about 70%. Seroprotection was 44% among those aged 20-49 and 30% among those 50-79 years. It was lowest among people aged 70-79 years (21%) and highest among those 90 years and older (88%).

Interpretation

We measured much higher levels of seroprotection after the 2009 pandemic compared than before the pandemic, with a U-shaped age distribution now evident. These findings, particularly the low levels of seroprotection among people aged 50-79 years, should be confirmed in other settings and closer to the influenza season.

SUBMITTER: Skowronski DM 

PROVIDER: S-EPMC2988533 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic.

Skowronski Danuta M DM   Hottes Travis S TS   Janjua Naveed Z NZ   Purych Dale D   Sabaiduc Suzana S   Chan Tracy T   De Serres Gaston G   Gardy Jennifer J   McElhaney Janet E JE   Patrick David M DM   Petric Martin M  

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20101018 17


<h4>Background</h4>Before pandemic (H1N1) 2009, less than 10% of serum samples collected from all age groups in the Lower Mainland of British Columbia, Canada, showed seroprotection against the pandemic (H1N1) 2009 virus, except those from very elderly people. We reassessed this profile of seroprotection by age in the same region six months after the fall 2009 pandemic and vaccination campaign.<h4>Methods</h4>We evaluated 100 anonymized serum samples per 10-year age group based on convenience sa  ...[more]

Similar Datasets

| S-EPMC2964451 | biostudies-other
2012-06-06 | GSE38502 | GEO
| S-EPMC3243696 | biostudies-literature
| S-EPMC2820088 | biostudies-literature
2013-04-17 | GSE46087 | GEO
| S-EPMC3204764 | biostudies-literature
2012-06-05 | E-GEOD-38502 | biostudies-arrayexpress
| S-EPMC2791228 | biostudies-other
| S-EPMC3485186 | biostudies-literature
| S-EPMC3294532 | biostudies-literature